Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissue.

Schut IC, Waterfall PM, Ross M, O'Sullivan C, Miller WR, Habib FK, Bayne CW.

BJU Int. 2003 Feb;91(3):278-83.

2.

Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.

Chakrabarti R, Robles LD, Gibson J, Muroski M.

Cancer Genet Cytogenet. 2002 Dec;139(2):115-25.

PMID:
12550771
3.

Expression analysis of Y chromosome genes in human prostate cancer.

Dasari VK, Goharderakhshan RZ, Perinchery G, Li LC, Tanaka Y, Alonzo J, Dahiya R.

J Urol. 2001 Apr;165(4):1335-41.

PMID:
11257712
4.

Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas.

Singh AP, Chauhan SC, Bafna S, Johansson SL, Smith LM, Moniaux N, Lin MF, Batra SK.

Prostate. 2006 Mar 1;66(4):421-9.

PMID:
16302265
5.

Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules.

Burke PA, Gregg JP, Bakhtiar B, Beckett LA, Denardo GL, Albrecht H, De Vere White RW, De Nardo SJ.

Int J Oncol. 2006 Jul;29(1):49-55.

PMID:
16773184
6.

Novel MUC1 splice variants are expressed in cervical carcinoma.

Obermair A, Schmid BC, Stimpfl M, Fasching B, Preyer O, Leodolter S, Crandon AJ, Zeillinger R.

Gynecol Oncol. 2001 Nov;83(2):343-7.

PMID:
11606095
7.

Expression of the developmental and oncogenic PAX2 gene in human prostate cancer.

Khoubehi B, Kessling AM, Adshead JM, Smith GL, Smith RD, Ogden CW.

J Urol. 2001 Jun;165(6 Pt 1):2115-20.

PMID:
11371938
8.

MUC1 expression in human prostate cancer cell lines and primary tumors.

O'Connor JC, Julian J, Lim SD, Carson DD.

Prostate Cancer Prostatic Dis. 2005;8(1):36-44.

PMID:
15477874
9.

[Tumor infiltrating dendritic cells and Mucin1 gene expression in benign prostatic hyperplasia and prostate cancer].

Xiang ST, Zhou SW, Guan W, Wang QZ, Zhang B, Liu JH, Ye ZQ.

Zhonghua Nan Ke Xue. 2003 Oct;9(7):497-500. Chinese.

PMID:
14628595
10.

NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension?

Cindolo L, Franco R, Cantile M, Schiavo G, Liguori G, Chiodini P, Salzano L, Autorino R, Di Blasi A, Falsaperla M, Feudale E, Botti G, Gallo A, Cillo C.

Eur Urol. 2007 Nov;52(5):1365-73. Epub 2006 Nov 20.

PMID:
17126478
11.

Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.

Zhong W, Peng J, He H, Wu D, Han Z, Bi X, Dai Q.

Clin Invest Med. 2008;31(1):E8-E15.

PMID:
18312749
12.
13.

DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer.

Dasari VK, Deng D, Perinchery G, Yeh CC, Dahiya R.

J Urol. 2002 Jan;167(1):335-8.

PMID:
11743352
14.

Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.

Schmid BC, Rudas M, Fabjani G, Speiser P, Kaserer K, Leodolter S, Zeillinger R.

Oncol Rep. 2003 Nov-Dec;10(6):1981-5.

PMID:
14534730
15.

Gene expression of forkhead transcription factors in the normal and diseased human prostate.

van der Heul-Nieuwenhuijsen L, Dits NF, Jenster G.

BJU Int. 2009 Jun;103(11):1574-80. doi: 10.1111/j.1464-410X.2009.08351.x. Epub 2009 Feb 11.

16.

Phenotypic and genotypic characterization of commonly used human prostatic cell lines.

Mitchell S, Abel P, Ware M, Stamp G, Lalani E.

BJU Int. 2000 May;85(7):932-44.

17.

Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer.

Mariani S, Salvatori L, Basciani S, Arizzi M, Franco G, Petrangeli E, Spera G, Gnessi L.

J Urol. 2006 Jun;175(6):2072-7; discussion 2077.

PMID:
16697805
18.

MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.

Cozzi PJ, Wang J, Delprado W, Perkins AC, Allen BJ, Russell PJ, Li Y.

Clin Exp Metastasis. 2005;22(7):565-73. Epub 2006 Feb 11.

PMID:
16475027
19.

Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.

Chandler JD, Williams ED, Slavin JL, Best JD, Rogers S.

Cancer. 2003 Apr 15;97(8):2035-42.

20.

Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situ.

Magro G, Schiappacassi M, Perissinotto D, Corsaro A, Borghese C, Belfiore A, Colombatti A, Grasso S, Botti C, Bombardieri E, Perris R.

J Pathol. 2003 Jul;200(3):357-69.

PMID:
12845632

Supplemental Content

Support Center